We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: Lors d’une réunion tenue le 13 novembre 2024, le Conseil d'administration de Valerio Therapeutics (“Valerio Therapeutics” or la “Société”) (Euronext Growth Paris : ALVIO) a...
Valerio Therapeutics acquires Emglev Therapeutics, a single-domain antibody-based therapeutics company The transaction was completed on September 29, 2024, enabling the acquisition of Emglev’s...
Regulatory News: Under the liquidity contract entered into between VALERIO THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30...
Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le...
Le premier niveau de dose, évaluant 3 patients de l'essai VIO-01-101, a été autorisé conformément aux recommandations du Comité d'examen clinique. Aucun événement indésirable cliniquement...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0048 | 6.74157303371 | 0.0712 | 0.082 | 0.07 | 121837 | 0.0753946 | DE |
4 | -0.0049 | -6.05686032138 | 0.0809 | 0.082 | 0.07 | 63496 | 0.07415081 | DE |
12 | -0.0021 | -2.68886043534 | 0.0781 | 0.12 | 0.07 | 106700 | 0.0893599 | DE |
26 | -0.034 | -30.9090909091 | 0.11 | 0.12 | 0.065 | 75956 | 0.08984418 | DE |
52 | -0.093 | -55.0295857988 | 0.169 | 0.1715 | 0.065 | 86564 | 0.10829859 | DE |
156 | -0.197 | -72.1611721612 | 0.273 | 0.348 | 0.065 | 80862 | 0.15280027 | DE |
260 | -0.197 | -72.1611721612 | 0.273 | 0.348 | 0.065 | 80862 | 0.15280027 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions